Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$0.92 - $1.29 $258,221 - $362,070
-280,675 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$0.75 - $1.81 $63,797 - $153,964
-85,063 Reduced 23.26%
280,675 $331,000
Q2 2019

Aug 14, 2019

SELL
$1.4 - $2.47 $189,516 - $334,361
-135,369 Reduced 27.01%
365,738 $589,000
Q4 2018

Feb 14, 2019

BUY
$1.98 - $3.01 $5,215 - $7,928
2,634 Added 0.53%
501,107 $992,000
Q3 2018

Nov 14, 2018

BUY
$2.6 - $3.14 $11,843 - $14,302
4,555 Added 0.92%
498,473 $1.55 Million
Q2 2018

Aug 14, 2018

BUY
$2.84 - $3.29 $25,946 - $30,057
9,136 Added 1.88%
493,918 $1.41 Million
Q4 2017

Feb 14, 2018

BUY
$3.07 - $4.68 $367,110 - $559,634
119,580 Added 32.74%
484,782 $1.49 Million
Q3 2017

Nov 14, 2017

BUY
$4.24 - $5.06 $449,825 - $536,820
106,091 Added 40.94%
365,202 $1.62 Million
Q2 2017

Aug 14, 2017

BUY
N/A
259,111
259,111 $1.31 Million

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $94.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Moon Capital Management LP Portfolio

Follow Moon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Moon Capital Management LP with notifications on news.